Literature DB >> 7827082

Mammalian protein geranylgeranyltransferase-I: substrate specificity, kinetic mechanism, metal requirements, and affinity labeling.

K Yokoyama1, P McGeady, M H Gelb.   

Abstract

Protein geranylgeranyltransferase-I (PGGT-I) catalyzes the transfer of the 20-carbon prenyl group from geranylgeranyl pyrophosphate to the cysteine residue near the C-termini of a variety of eukaryotic proteins. Kinetic analysis of homogenous PGGT-I from bovine brain reveals that the reaction follows a sequential pathway in which either prenyl donor or acceptor can bind first to the enzyme and that the reaction operates at steady-state rather than at rapid equilibrium. Substrate inhibition by prenyl acceptor but not by prenyl donor suggests that geranylgeranyl pyrophosphate binding first to free enzyme is the kinetically preferred pathway. This is supported by isotope trapping experiments which show that the ternary complex goes on to products faster than the release of geranylgeranyl pyrophosphate from the complex. The KM for the interaction of geranylgeranyl pyrophosphate with PGGT-I is markedly affected by the structure of the prenyl acceptor bound to the enzyme. A detailed analysis of the substrate specificity of PGGT-I reveals that peptides which contain a C-terminal leucine are preferred (kcat/KM = 1-5 x 10(5) M-1 s-1) to those that end in serine (kcat/KM = 2-4 x 10(3) M-1 s-1) or phenylalanine (kcat/KM = 0.5 x 10(3) M-1 s-1). PGGT-I also catalyzes the farnesylation of peptides that have a C-terminal leucine; kcat for farnesylation and KM for farnesyl pyrophosphate are similar to those for geranylgeranylation, but the KM for the peptide is 30-fold higher. Geranyl pyrophosphate is utilized by PGGT-I but is a poor substrate. Optimal activity of PGGT-I is obtained in the presence of micromolar amounts of Zn2+ and mM amounts of Mg2+. Mn2+ or Cd2+ but not Co2+ can substitute for Zn2+ and for Mg2+. Metals are not required for tight-binding of geranylgeranyl pyrophosphate to PGGT-I, and the measured dissociation equilibrium constant for this binary complex is 16 nM. Photoaffinity analogues of geranylgeranyl pyrophosphate and farnesyl pyrophosphate were prepared and shown to exclusively label the beta-subunit. The implication of the results for the substrate specificity of protein prenylation in cells is briefly discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7827082     DOI: 10.1021/bi00004a029

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  24 in total

Review 1.  Farnesyl protein transferase inhibitors and other therapies targeting the Ras signal transduction pathway.

Authors:  D W End
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

2.  Photoaffinity labeling of Ras converting enzyme 1 (Rce1p) using a benzophenone-containing peptide substrate.

Authors:  Kelly Kyro; Surya P Manandhar; Daniel Mullen; Walter K Schmidt; Mark D Distefano
Journal:  Bioorg Med Chem       Date:  2010-06-12       Impact factor: 3.641

Review 3.  How to Target Activated Ras Proteins: Direct Inhibition vs. Induced Mislocalization.

Authors:  Ethan J Brock; Kyungmin Ji; John J Reiners; Raymond R Mattingly
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

4.  Functional implications of structural predictions for alternative splice proteins expressed in Her2/neu-induced breast cancers.

Authors:  Rajasree Menon; Ambrish Roy; Srayanta Mukherjee; Saveliy Belkin; Yang Zhang; Gilbert S Omenn
Journal:  J Proteome Res       Date:  2011-10-28       Impact factor: 4.466

5.  Dexamethasone-induced decrease in HMG-CoA reductase and protein-farnesyl transferase activities does not impair ras processing in AR 4-2J cells.

Authors:  M Lambert; N D Bui
Journal:  Mol Cell Biochem       Date:  1999-12       Impact factor: 3.396

6.  Protein geranylgeranyltransferase-I of Trypanosoma cruzi.

Authors:  Kohei Yokoyama; John R Gillespie; Wesley C Van Voorhis; Frederick S Buckner; Michael H Gelb
Journal:  Mol Biochem Parasitol       Date:  2007-10-02       Impact factor: 1.759

7.  A photoactive isoprenoid diphosphate analogue containing a stable phosphonate linkage: synthesis and biochemical studies with prenyltransferases.

Authors:  Amanda J DeGraw; Zongbao Zhao; Corey L Strickland; A Huma Taban; John Hsieh; Michael Jefferies; Wenshuang Xie; David K Shintani; Colleen M McMahan; Katrina Cornish; Mark D Distefano
Journal:  J Org Chem       Date:  2007-05-04       Impact factor: 4.354

8.  Synthesis, properties, and applications of diazotrifluropropanoyl-containing photoactive analogs of farnesyl diphosphate containing modified linkages for enhanced stability.

Authors:  Marisa L Hovlid; Rebecca L Edelstein; Olivier Henry; Joshua Ochocki; Amanda DeGraw; Stepan Lenevich; Trista Talbot; Victor G Young; Alan W Hruza; Fernando Lopez-Gallego; Nicholas P Labello; Corey L Strickland; Claudia Schmidt-Dannert; Mark D Distefano
Journal:  Chem Biol Drug Des       Date:  2010-01       Impact factor: 2.817

9.  Farnesylcysteine lyase is involved in negative regulation of abscisic acid signaling in Arabidopsis.

Authors:  David H Huizinga; Ryan Denton; Kelly G Koehler; Ashley Tomasello; Lyndsay Wood; Stephanie E Sen; Dring N Crowell
Journal:  Mol Plant       Date:  2009-11-10       Impact factor: 13.164

10.  A versatile photoactivatable probe designed to label the diphosphate binding site of farnesyl diphosphate utilizing enzymes.

Authors:  Olivier Henry; Fernando Lopez-Gallego; Sean A Agger; Claudia Schmidt-Dannert; Stephanie Sen; David Shintani; Katrina Cornish; Mark D Distefano
Journal:  Bioorg Med Chem       Date:  2009-04-22       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.